MIB‐1 and S‐phase cell fraction predict survival in non‐Hodgkin's lymphomas
- 1 January 1997
- journal article
- research article
- Published by Wiley in Cell Proliferation
- Vol. 30 (1) , 37-47
- https://doi.org/10.1046/j.1365-2184.1997.00066.x
Abstract
The monoclonal antibody anti-Ki67 is used to detect proliferating cells, but its main limitation is the requirement of fresh-frozen material. On a series of patients with non-Hodgkin's lymphoma, we u...Keywords
This publication has 26 references indexed in Scilit:
- Primary gastric lymphoma. A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 indexCancer, 1995
- S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphomaCancer, 1995
- Cell proliferation as a long-term prognostic factor in diffuse large-cell lymphomasInternational Journal of Cancer, 1993
- Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathologyCytometry, 1993
- Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sectionsThe Journal of Pathology, 1992
- Prognostic implications of cell kinetics, histopathology and pathologic stage in non‐Hodgkin's lymphomasHematological Oncology, 1989
- Determination of proliferative fractions detected by immunohistochemistry with the monoclonal antibodies to bromodeoxyuridine and Ki-67 in malignant lymphomasHematological Oncology, 1989
- The prognostic value of Ki67 immunostaining in non‐Hodgkin's lymphomaThe Journal of Pathology, 1988
- Comparative analysis of [3H]-thymidine labelling index and monoclonal antibody Ki-67 in non-Hodgkin's lymphomasHematological Oncology, 1987
- Growth fractions in malignant non‐Hodgkin's lymphomas (NHL) as determinedin situwith the monoclonal antibody Ki‐67Hematological Oncology, 1984